
Our body is a mosaic of fungi. Some scientists think they could be influencing our brain
Amongst the millions of tiny life forms living on and inside our bodies are countless species of fungi. Our skin is a mosaic of them, membranes inside the nose and vagina are full of them, and fungi even live alongside the bacteria inside our guts.
While we might acquire some fungi from our mothers at birth, new fungi are also constantly entering our bodies; we ingest yeasts every time we drink beer or eat bread, and we inhale floating fungal spores with every breath. Many of these fungi are quickly killed off by our immune systems, but others are transient passengers or lifelong acquaintances.
Lately, scientists have been exploring how our fungal inhabitants could even influence our brains, minds and behaviour.
Doctors have long known that fungi can cause dangerous brain infections. But researchers are now also finding curious – albeit sometimes controversial – hints that these microbes might have other neurological effects on humans.
The idea might evoke images of the human-zombifying fungus from HBO's apocalyptic series The Last of Us. But while scientists agree that the idea of fungi taking complete control over our bodies is implausible, they're earnestly investigating whether some fungi inside us could contribute to brain-damaging diseases, or if gut-dwelling fungi could influence our behaviour and mental health.
Much more research is needed, experts say. But these possibilities are important to study – both to understand the deep and complex relationships with the microbes within us and to explore new ways of boosting our health.
In general, humans are pretty good at resisting fungi (our warm body temperature tends to make it hard for them to take hold). And many of the fungi that do might actually be good for us, possibly supporting our immune systems or helping wounds to heal, says microbiologist Matthew Olm of the University of Colorado Boulder, US. "I would say fungi are definitely a critical part of being a healthy human," he says.
But many other fungi can cause infections, from athlete's foot to thrush. This happens when we encounter new, harmful fungi in our environment or when fungi that naturally coexist with us are under certain conditions triggered to explode in abundance, says Rebecca Drummond, a fungal immunologist at the University of Birmingham, UK.
It's rare for fungi to reach the brain, thanks to protective barriers in the lungs and intestines, along with the brain's own defensive wall, the blood-brain barrier, and immune cells that are primed to destroy any fungi that slip through. But fungal brain infections do happen, and the number of cases has increased in recent decades.
This is due to a growing number of people with weakened immune systems, Drummond says, partly because of the global spread of the immune-crippling virus HIV, especially in parts of Africa but also due to rising use of immune-suppressing medications in cancer patients and organ transplant recipients. "The more of these immune-modulating drugs we use, we'll see more of these fungal infections," Drummond says.
Fungi that infect the brain sometimes originate in the lungs, including Aspergillus or Cryptococcus, which we inhale as airborne spores that can germinate, grow and spread if left unchecked, Drummond says. Less often, common gut residents such as Candida albicans grow out of control and, once in the brain, branches out and produces nerve-killing toxins, Drummond adds. Cryptococcus, meanwhile, can grow into tumour-like masses. "Obviously, that causes huge amounts of damage," she says.
Fungal brain infections are often fatal, with Aspergillus reaching mortality rates of above 90%. They can be tricky to treat, says Drummond: there aren't many antifungal medications, and not all drugs get across the blood-brain barrier to kill off brain-dwelling fungi. Some fungi have also already developed resistance to these drugs.
People who survive fungal infections of the brain are often left with long-term brain damage. Aids patients who have survived cryptococcal meningitis, which arises from a brain infection by Cryptococcus x, suffer vision impairments, memory loss and dizziness, says Drummond.
Scientists have long known of the dangers of fungal brain infections. But in recent years, some have been exploring the possibility that fungi are getting into the brain much more frequently than previously believed, and may even be contributing to the loss of nerve cells that occurs in conditions like Alzheimer's disease.
To Richard Lathe, a molecular biologist at the University of Edinburgh, UK, some of the most interesting evidence for this theory comes from a handful of cases where fungal and other microbial brain infections were coincidentally discovered in people initially diagnosed with Alzheimer's disease. In several cases where doctors prescribed infection-fighting medication, "the symptoms of dementia remitted", Lathe says. "Quite remarkably, some of them went back to work".
Lathe believes that microbes slip across the blood-brain barrier quite frequently but are usually suppressed or killed in people with healthy immune systems. Because our immune systems weaken with age, that could allow microbes to accumulate in the brain, perhaps triggering nerve-killing inflammation. "It's only when the immune system declines that you see damage," he says.
Scientists have long linked Alzheimer's to a build-up of certain proteins in the brain, but there's now a growing debate over whether the presence of those proteins is the cause or merely a symptom of the disease. Lathe argues these proteins are actually produced as a defence mechanism against microbial intrusion, based on research suggesting the proteins have infection-fighting properties.
Further evidence that brain-intruding microbes could be causing Alzheimer's comes from experiments in mice, where scientists have witnessed the fungus Candida albicans entering the brain after the rodents' immune systems were compromised. And in one pre-print study – which hasn't yet been peer-reviewed by other scientists – Lathe and his colleagues examined brain slices from deceased healthy people and Alzheimer's patients. They found large quantities of bacteria, viruses and fungi in both groups – but more in the brains from patients who had Alzheimer's.
If microbes are indeed a factor in Alzheimer's, we may be able to mitigate or even prevent the disease by strengthening people's immune defences, for instance with vaccines that have been shown to boost general immunity. But this theory is young, Lathe says. "It's a new idea."
And a debated one, too. Olm and others argue it's hard to rule out that the microbial genetic material may have appeared because of contamination, as fragments of microbes tend to be ubiquitous. Lathe finds that unlikely, though, pointing to reports that microbe fragments in brain tissue are just as abundant inside the samples as they are on the surface, whereas contamination from the air would mostly settle on the brain surface.
Still, Olm says that finding more microbe fragments in Alzheimer's brains isn't proof that those microbes cause the disease. For instance, those people's brains might simply have had a weaker blood-brain barrier or some other issue, meaning more microbes entered their brains over time before being killed off by their immune systems.
However, new evidence that microbes can invade the brains of animals like fish strengthens the notion that this could be happening in mammals – and perhaps even humans, Olm says. In a 2024 study, scientists labelled bacteria with tiny, fluorescent green molecules and added them to tanks housing salmon and trout. "After a week, you see these microbes making their way into the fish brain, lighting the fish brain up green," Olm says, and curiously, "[the microbes] seemingly live there without huge consequences for these fish over their lifetime."
In any case, the notion of fungi and other microbes getting into the brain in old age – either due to a weakening brain immune system or a worn-out blood brain barrier – is more plausible. "I think we've now reached that threshold where there's enough smoke around this hypothesis… it's worth spending money on figuring out if that is happening," Olm says.
More like this:• What your snot can reveal about your health• Why the microbes that live on your skin matter• The mystery origins of Candida auris
Interestingly, fungi might not need to enter the brain in order to influence it.
In a 2022 study, immunologist Iliyan Iliev of Weill Cornell Medicine in the US and colleagues found that adding Candida albicans to the guts of mice made them more resilient to damage of their gut linings caused by bacterial infections or heavy antibiotic use. Strengthening the gut wall may be a defence mechanism by the body to prevent the fungus and other microbes from escaping the gut and infecting other tissues, Iliev says.
But the big surprise came when the team observed the rodents' behaviour. Remarkably, fungi-colonised mice were much more likely to sniff, communicate and engage with other mice – meaning that exposure to the fungi appeared to have some sort of behavioural effect too. Based on other experiments, the scientists theorise that certain molecules released by the mice's immune cells enter the bloodstream and somehow stimulate certain nerve cells in the brain that are involved in behaviour. "It was very surprising to us," Iliev recalls.
It's a mystery why, at least in mice, this crosstalk between gut fungi and the brain exists. Is it a coincidence that fungus-triggered immune signals affect the brain, or "is that actually deliberately done by the fungus to benefit its survival?" Iliev asks. Perhaps mammalian bodies somehow benefit from changing their behaviour in response to fungi, Iliev speculates.
There's no evidence yet that this crosstalk between gut fungi and the brain happens in humans, but the possibility would be worth investigating, Olm says. In recent years, evidence has mounted that gut-dwelling bacteria may be able to send signals to the brain via the immune and nervous systems, or by producing substances associated with the symptoms of depression, anxiety, and relaxation. In principle, Olm says, "there's no reason to think that fungi aren't doing this as well". (Read more about how gut bacteria could be influencing the brain).
Some scientists are even investigating whether fungi could be involved in mental disorders. Several studies have found differences in the makeup of gut fungi in people who suffer from depression or bipolar disorder.
In women with schizophrenia, those who showed signs of exposure to the gut-dwelling Candida albicans tended to score lower on tests of memory and other cognitive abilities, according to a 2016 study by Johns Hopkins neuroscientist Emily Severance and her colleagues. She is exploring the possibility that Candida overgrowth – caused by stress or antibiotics, for instance – provokes an imbalance of gut microbes, altering the substances they produce in ways that make susceptible people more likely to develop schizophrenia. If true, it could allow doctors to treat schizophrenia symptoms by giving people probiotics that help reverse the overabundance of Candida – which would in any case be helpful, she says.
But finding an association doesn't mean that the fungi cause schizophrenia. It could simply be that these patients are somehow more prone to high levels of Candida. So far "we can only come up with associations", says Severance. 'I think that that's typical for a field of study that is very exciting – but still very early on in the timeline.'
Which of our fungal inhabitants – if any at all – are really influencing our brains is something scientists hope to learn in the coming years. "[Fungi are] definitely important," Drummond says, "but exactly how they're important, I think, is still being worked out." One thing is already clear: while bacteria have long been in the limelight, it may be time we also pay serious attention to the fungi quietly shaping our health from within.
--
For trusted insights into better health and wellbeing rooted in science, sign up to the Health Fix newsletter, while The Essential List delivers a handpicked selection of features and insights.
For more science, technology, environment and health stories from the BBC, follow us on Facebook, X and Instagram.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


BBC News
25 minutes ago
- BBC News
Man wearing heavy metallic necklace dies after being sucked into MRI machine
A 61-year-old man has died after he was sucked into a Magnetic Resonance Imaging (MRI) machine at a medical centre while he was wearing a heavy metal necklace. The man, who has not been identified, entered a room at Nassau Open MRI in Westbury, on New York's Long Island, without permission as the MRI machine was running, Nassau County Police Department said. A patient at the facility told local media her husband was the one who died. She said she had called him into the room after she had a scan on say the incident "resulted in a medical episode" and the man was taken to the hospital, where he died on Thursday. MRI machines use a strong magnetic field to produce detailed images. Patients are typically asked to remove metal items and change out of their clothes before undergoing MRI scans or going near the machine. "The male victim was wearing a large metallic chain around his neck causing him to be drawn into the machine, which resulted in a medical episode," said Nassau County Police Department, which is investigating the incident. Though police have not named the victim, a woman, Adrienne Jones-McAllister, told local television station News 12 Long Island that it was her husband, Keith, who died. "He waved goodbye to me and then his whole body went limp," she said tearfully. Ms Jones-McAllister told the outlet she was getting an MRI on her knee and asked her husband to come in to help her get up afterwards. She said he was wearing a 20lb (9kg) chain with a lock that he used for weight training."At that instant, the machine switched him around, pulled him in, and he hit the MRI," she Jones-McAllister said the technician had tried to pull her husband away from the machine."I'm saying, 'Could you turn off the machine?" she told the outlet. "Call 911. Do something. Turn this damn thing off!'"The BBC has contacted Nassau Open MRI for comment. According to the US Food and Drug Administration, MRI machines have magnetic fields that will attract magnetic objects of all sizes - keys, mobile phones and even oxygen tanks - which "may cause damage to the scanner or injury to the patient or medical professionals if those objects become projectiles". In 2001, a six-year-old boy died of a fractured skull at a New York City medical centre while undergoing an MRI exam after its powerful magnetic force propelled an oxygen tank across the room.


Daily Mail
an hour ago
- Daily Mail
Netanyahu's appearance in court is delayed as PM has food poisoning, his office says
Benjamin Netanyahu has been hit with food poisoning and ordered by doctors to conduct state affairs from home for the next three days. On Sunday, the Israeli Prime Minister's office announced the 75-year-old is recovering at home after being diagnosed with intestinal inflammation caused by spoiled food. Due to the sudden bout of sickness, Netanyahu's upcoming hearings in his corruption trial have now been postponed. The next court appearance will not come before September now, due to a summer recess in the court system. Netanyahu was examined overnight by Professor Alon Hershko of Jerusalem's Hadassah-Ein Kerem Medical, after skipping a cabinet meeting on Saturday, and is now receiving intravenous fluid treatment for dehydration. 'In accordance with his doctors' instructions, the prime minister will rest at home for the next three days and will conduct state affairs from there,' says the Prime Minister's Office. Netanyahu's condition was declared 'good' after further testing, his office added. The leader had been scheduled to give testimony in court tomorrow and Tuesday but his lawyer Amit Hadad requested that the hearings be postponed and asked for a delay. The request filed with the Jerusalem District Court on his behalf said that the premier will 'make an effort' to testify on Wednesday instead. The leader had been scheduled to give testimony in court tomorrow and Tuesday but his lawyer Amit Hadad requested that the hearings be postponed and asked for a delay The State Attorney's Office earlier agreed to postpone the two scheduled hearings after reviewing Netanyahu's medical records, but said that they must be made up by the end of the week. 'Under the circumstances, and considering what is written in the medical record, we cannot object,' it said in response. 'However, in light of the many hearings that have been canceled recently, we will request that the defendant testify on Wednesday and Thursday of this week.' The court said, however, that it was canceling the hearings rather than postponing them, as they could not be held later in the week due to scheduling conflicts. This means Netanyahu will not testify again until September at the earliest, as the courts head into summer recess this week until September 5. During the recess, courts will operate in a reduced capacity. Netanyahu's testimony has been repeatedly delayed since it started in December last year, due to the prime minister's medical issues, the ongoing war with Hamas in Gaza, the war with Iran, as well as diplomatic trips abroad and Netanyahu's general duties as prime minister. Just last month, an Israeli court cancelled hearings in Netanyahu's long-running corruption trial, accepting a request made by the prime minister on classified diplomatic and security grounds. 'Following the explanations given … we partially accept the request and cancel at this stage Mr Netanyahu's hearings scheduled for this week', the Jerusalem district court said in its ruling, published online by Netanyahu's Likud party. The ruling said that new reasons provided by Netanyahu, the head of Israel's spy agency the Mossad and the military intelligence chief justified cancelling the hearings. Israeli Prime Minister Benjamin Netanyahu appears before the District Court in Tel Aviv to testify for the first time in his corruption trial in Tel Aviv, Israel on December 10, 2024 Also last month, US President Donald Trump called for Israel to 'pardon' Netanyahu, who is on trial for alleged corruption, or drop the case altogether. The Israeli prime minister has denied charges of bribery, fraud and breach of trust, for which he has been on trial since 2020. The recent food poisoning incident is not the first time the Israeli Prime Minister's health has made headlines, as he has suffered from several health issues in recent years. He had his prostate removed in late December, and in March 2024, he was had hernia surgery. That same month, he missed several days of work after contracting the flu. In 2023, he underwent surgery to have a pacemaker installed after suffering a transient heart block. A week earlier he he had been hospitalised for what he said at the time was dehydration. Doctors subsequently revealed that the prime minister has had a heart conduction problem for years. Netanyahu's most recent public medical report, issued in January 2023, described him as in a 'completely normal state of health,' with no signs of arrhythmia and the pacemaker functioning properly. The document, however, was not an official government health report but rather a summary compiled by his personal medical team. Despite government protocols urging prime ministers to release annual health summaries, Netanyahu issued no such report between 2016 and 2023, and none has been released this year. Those protocols are not legally binding, and he cannot be compelled to disclose his medical history.


The Guardian
2 hours ago
- The Guardian
Superbugs could kill millions more and cost $2tn a year by 2050, models show
Superbugs could cause millions more people to die worldwide and cost the global economy just under $2tn a year by 2050, modelling shows. A UK government-funded study shows that without concerted action, increased rates of antimicrobial resistance (AMR) could lead to global annual GDP losses of $1.7tn over the next quarter of a century. The research, by the Center for Global Development thinktank, found the US, UK and EU economies would be among the hardest hit, prompting accusations that recent swingeing aid cuts are self-defeating. On Thursday, the UK government announced it was axing funding for the Fleming fund, which combats AMR in low- and middle-income countries, as part of wider aid cuts. The Trump administration has confirmed $9bn in cuts to its foreign aid budget, while a number of European countries have also reduced spending on overseas aid. Anthony McDonnell, the lead author and the research and a policy fellow at the Center for Global Development, said: 'When we conducted our research on the economic impacts of antimicrobial resistance, it was anticipated that resistance rates would continue to follow historical trends. 'However, the sudden cuts to Official Development Assistance by the US, which has cut its aid spend by roughly 80%; the UK, which has announced aid cuts from 0.5% to 0.3% of gross national income; and substantial reductions by France, Germany, and others, could drive up resistance rates in line with the most pessimistic scenario in our research. 'Even countries that have been successful in keeping AMR rates under control cannot afford to be complacent. Unless AMR programmes are protected from aid cuts, resistance rates across the world will likely increase at a rate in line with the worst-affected countries. 'This would result in millions more people dying worldwide, including across G7 nations. Investing in treatment for bacterial infections now will save lives and deliver billions in long-term economic returns.' The research calculated the economic and health burden of antibiotic resistance for 122 countries and forecast that in that in this most pessimistic scenario, by 2050, GDP losses in China could reach just under $722bn a year, the US $295.7bn, the EU $187bn, Japan $65.7bn and the UK $58.6bn. According to the Institute for Health Metrics and Evaluation (IHME), deaths from AMR are expected to increase 60% by 2050, with 1.34 million people in the US and 184,000 in the UK alone predicted to die each year from antibiotic resistant bugs, while numbers of those becoming seriously ill from drug-resistant bacteria are also expected to jump. Superbugs increase the number of hospital admissions and lead to longer and more intensive hospital stays, costlier second-line treatments and more complex care, meaning resistant infections are roughly twice as expensive to treat as those for which antibiotics are effective. The study estimates global health costs of treating AMR could increase by just under $176bn a year, while in the UK, they would rise from $900m to $3.7bn and in the US from $15.5bn to just under $57bn. Higher rates of resistant bugs would also shrink the UK, EU and US workforces by 0.8%, 0.6% and 0.4% respectively, the study found. But if countries invest more in tackling superbugs – increasing access to new antibiotics and high-quality treatment of these infections – the US economy would grow $156.2bn a year and the UK $12bn (£9.3bn) by 2050. Responding to the findings, Dr Mohsen Naghavi, a professor of health metrics at IHME, said: 'Today the threat of AMR is increasing, and without immediate action from all stakeholders the medicines we have access to now could stop working, potentially causing a simple infection to become deadly.' That would involve policy changes from the US, European and UK governments, the development of new drugs and ensuring everyone understood that antibiotics were ineffective against viruses, he added. A UK government spokesperson said: 'Our 10-year health plan recognises antimicrobial resistance (AMR) as a major threat and commits to urgently tackle its spread, including through new vaccines. 'We have made important progress - reducing antibiotic use in meat and pioneering a world-first subscription model to incentivise the development of new treatments. We also continue to work closely with international partners to influence global efforts to limit the spread of AMR.'